Growth Metrics

Dexcom (DXCM) Capital Expenditures Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -17.56%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 34.96%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -6.72%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -5.35%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 15.89%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -47.73%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -11.95%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -43.42%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 27.22%
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn -18.61%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -11.95%
Dec 31, 2025 -18.22%
Sep 30, 2025 -27.61%
Jun 30, 2025 42.36%
Mar 31, 2025 52.90%
Dec 31, 2024 137.33%
Sep 30, 2024 120.63%
Jun 30, 2024 12.03%
Mar 31, 2024 -23.83%
Dec 31, 2023 -17.32%
Sep 30, 2023 -53.42%
Jun 30, 2023 -35.52%
Mar 31, 2023 -26.48%
Dec 31, 2022 -20.82%
Sep 30, 2022 0.09%
Jun 30, 2022 -9.58%
Mar 31, 2022 1.91%
Dec 31, 2021 33.22%
Sep 30, 2021 128.06%
Jun 30, 2021 73.88%
Mar 31, 2021 200.30%
Dec 31, 2020 36.51%
Sep 30, 2020 -4.63%
Jun 30, 2020 24.09%
Mar 31, 2020 -15.52%
Dec 31, 2019 149.15%
Sep 30, 2019 108.82%
Jun 30, 2019 355.34%
Mar 31, 2019 156.86%
Dec 31, 2018 0.57%
Sep 30, 2018 76.30%
Jun 30, 2018 -14.17%
Mar 31, 2018 -33.19%
Dec 31, 2017 0.00%
Sep 30, 2017 -16.15%
Jun 30, 2017 14.29%
Mar 31, 2017 99.13%
Dec 31, 2016 51.72%
Sep 30, 2016 117.57%
Jun 30, 2016 66.67%
Mar 31, 2016 43.75%
Dec 31, 2015 152.17%
Sep 30, 2015 100.00%
Jun 30, 2015 57.50%
Mar 31, 2015 105.13%
Dec 31, 2014 100.00%
Sep 30, 2014 68.18%
Jun 30, 2014 100.00%
Mar 31, 2014 178.57%
Dec 31, 2013 64.29%
Sep 30, 2013 -24.14%
Jun 30, 2013 -31.03%
Mar 31, 2013 -39.13%
Dec 31, 2012 -60.49%
Sep 30, 2012 92.56%
Jun 30, 2012 150.00%
Mar 31, 2012 28.42%
Dec 31, 2011 49.75%
Sep 30, 2011 -28.05%